(滑动查看全部)
1. Lessa, F.C. et al. (2015) Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 825–834
2. Dubberke, E.R. and Olsen, M.A. (2012) Burden of Clostridium difficile on the healthcare system. Clin. Infect. Dis. 55, S88–S92
3. Raibaud, P. et al. (1974) Sodium taurocholate, a germination factor for anaerobic bacterial-spores in vitro and in vivo. Ann. Microbiol. B125, 381–391
4. Voth, D.E. and Ballard, J.D. (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247–263
5. Hall, I.C. and O’Toole, E. (1935) Intestinal flora in new-born infants – with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis. Children 49, 390–402
6. Bartlett, J.G. et al. (1978) Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75, 778–782
7. Best, E.L. et al. (2012) Models for the study of Clostridium difficile infection. Gut Microbes 3, 145–167
8. Oka, K. et al. (2018) Establishment of an endogenous Clostridium difficile rat infection model and evaluation of the effects of Clostridium butyricum MIYAIRI 588 probiotic strain. Front. Microbiol. 9, 1264
9. Hutton, M.L. et al. (2014) Small animal models for the study of Clostridium difficile disease pathogenesis. FEMS Microbiol. Lett. 352, 140–149
10. Abt, M.C. et al. (2016) Clostridium difficile colitis: pathogenesis and host defence. Nat. Rev. Microbiol. 14, 609–620
11. https://www./trends/microbiology/fulltext/S0966-842X(18)30200-2